| Product |
CAS |
Molecular formula |
More |
| 2-(N-tert-butoxycarbonyl-n-methyl)-amino-3,3-diphenyl-propanoic acid m |
182493-16-9 |
C22H27NO4 |
More |
| (1-Hydroxymethyl-2,2-diphenyl-ethyl)-methyl-carbamic acid tert-butyl e |
182493-18-1 |
C21H27NO3 |
More |
| 5-Amino-4-(3-acetylaminobenzoyl)-1-phenylpyrazole |
249937-50-6 |
C18H16N4O2 |
More |
| 2-Amino-4-difluoromethyl-5-iodo-benzoic acid methyl ester |
912575-06-5 |
C9H8F2INO2 |
More |
| 5-(2-Bromophenyl)-2-(tetrahydropyran-2-yl)-2h-tetrazole |
676130-02-2 |
C12H13BrN4O |
More |
| 5-(2-Chlorophenyl)-1-(tetrahydropyran-2-yl)-1h-tetrazole |
676130-01-1 |
C12H13ClN4O |
More |
| 5-(2-Bromophenyl)-1-(tetrahydropyran-2-yl)-1h-tetrazole |
676130-03-3 |
C12H13BrN4O |
More |
| 2-(5-Bromo-2-chloro-pyrimidin-4-ylamino)-n-methyl-benzamide |
761440-09-9 |
C12H10BrClN4O |
More |
| 2-(5-Bromo-2-chloro-pyrimidin-4-ylamino)-n-methyl-benzenesulfonamide |
761440-01-1 |
C11H10BrClN4O2S |
More |
| 7-(2,5-Dichloro-pyrimidin-4-ylamino)-2-methyl-2.3-dihydro-isoindol-1-o |
761440-07-7 |
C13H10Cl2N4O |
More |
| 5-Bromo-4-cyclopentylamino-pyrimidine-2-carbonitrile |
1024589-35-2 |
C10H12BrN5 |
More |
| 4-[(2,2-Dimethyl-propyl)-(4-iodo-benzyl)-amino]-pyrimidine-2-carbonitr |
669004-39-1 |
C17H19IN4 |
More |
| Methyl 3-(5-p-tolylisoxazol-3-yl)benzoate |
745055-71-4 |
C18H15NO3 |
More |
| 3-[3-(4-Methoxyphenyl)-1,2,4-oxadiazol-5-yl]benzoic acid |
745055-33-8 |
C16H12N2O4 |
More |
| 2-Chloro-4-[3-(4-chloro-phenyl)-1h-pyrazol-4-yl]pyrimidine |
646527-96-0 |
C13H8Cl2N4 |
More |
| 6-Bromomethyl-7-(3,3-dimethyl-butyl)-7h-pyrrolo[2,3-d]pyrimidine-2-car |
742067-08-9 |
C14H17BrN4 |
More |
| 6-Chloromethyl-7-(2-cyclohexyl-ethyl)-7h-pyrrolo[2,3-d]pyrimidine-2-ca |
742067-38-5 |
C16H19ClN4 |
More |
| 7-(2,2-Dimethyl-propyl)-6-(1,3-dioxo-2,8-diaza-spiro[4.5]dec-2-ylmethy |
752234-53-0 |
C21H26N6O2 |
More |
| 7-(4-Fluorobenzyl)-7,8-dihydroimidazo[1,5-a]pyrazin-6-one |
660855-07-2 |
C13H12FN3O |
More |
| 4-(7-Benzyl-6-oxo-5,6,7,8-tetrahydroimidazo[1,5-a]pyrazin-5-yl)benzoni |
660854-20-6 |
C20H16N4O |
More |
